Literature DB >> 1693219

Multiplication of human immunodeficiency virus in primary cultures of human Kupffer cells--possible role of liver macrophage infection in the physiopathology of AIDS.

M P Schmitt1, A M Steffan, J L Gendrault, D Jaeck, C Royer, C Schweitzer, C Beyer, C Schmitt, A M Aubertin, A Kirn.   

Abstract

In primary cultures of Kupffer cells obtained from surgical biopsies of human liver by collagenase perfusion followed by centrifugal elutriation and infected with HIV, the virus multiplied abundantly, as attested by the appearance of a reverse transcriptase activity in the medium. Examined by electron microscopy, the cells were found to contain viral particles with typical features of Lentivirinae. Furthermore, the virus could be revealed by immunofluorescence using an HIV+ patient serum. HIV antibodies also neutralized the infectivity of the Kupffer cell-produced virus. Our results demonstrate that the cells constituting the largest fraction of fixed macrophages in the body may be infected by HIV, thereby suggesting that the Kupffer cells may play a role in the physiopathology of the disease, namely as a reservoir for the virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1693219     DOI: 10.1016/0923-2516(90)90016-c

Source DB:  PubMed          Journal:  Res Virol        ISSN: 0923-2516


  14 in total

1.  Circulating monocytes are not a major reservoir of HIV-1 in elite suppressors.

Authors:  Adam M Spivak; Maria Salgado; S Alireza Rabi; Karen A O'Connell; Joel N Blankson
Journal:  J Virol       Date:  2011-07-27       Impact factor: 5.103

2.  No recovery of replication-competent HIV-1 from human liver macrophages.

Authors:  Abraham J Kandathil; Sho Sugawara; Ashish Goyal; Christine M Durand; Jeffrey Quinn; Jaiprasath Sachithanandham; Andrew M Cameron; Justin R Bailey; Alan S Perelson; Ashwin Balagopal
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

3.  Kinetics of liver macrophages (Kupffer cells) in SIV-infected macaques.

Authors:  Muhammad H Ahsan; Amy F Gill; Xavier Alvarez; Andrew A Lackner; Ronald S Veazey
Journal:  Virology       Date:  2013-08-19       Impact factor: 3.616

Review 4.  Aging of the Liver: What This Means for Patients with HIV.

Authors:  Austin W Chan; Yuval A Patel; Steve Choi
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

5.  The association of HIV viral load with indirect markers of liver injury.

Authors:  J E Forrester; M S Rhee; B H McGovern; R K Sterling; T A Knox; N Terrin
Journal:  J Viral Hepat       Date:  2011-12-02       Impact factor: 3.728

6.  Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.

Authors:  Ashwin Balagopal; Stuart C Ray; Ruben Montes De Oca; Catherine G Sutcliffe; Perumal Vivekanandan; Yvonne Higgins; Shruti H Mehta; Richard D Moore; Mark S Sulkowski; David L Thomas; Michael S Torbenson
Journal:  AIDS       Date:  2009-11-27       Impact factor: 4.177

Review 7.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

8.  Human peritoneal macrophages from ascitic fluid can be infected by a broad range of HIV-1 isolates.

Authors:  Theresa L Chang; Arielle Klepper; Jian Ding; John Garber; Aprille Rapista; Arevik Mosoian; Wolfgang Hubner; Julio Gutierrez; Jose Walewski; Jeffrey Abergel; Thomas Schiano; Andrea Branch
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

Review 9.  Host and Viral Factors Influencing Interplay between the Macrophage and HIV-1.

Authors:  Viviane Machado Andrade; Mario Stevenson
Journal:  J Neuroimmune Pharmacol       Date:  2018-07-11       Impact factor: 4.147

Review 10.  Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream.

Authors:  Stephanie E Ander; Frances S Li; Kathryn S Carpentier; Thomas E Morrison
Journal:  PLoS Pathog       Date:  2022-05-05       Impact factor: 7.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.